Zevra Therapeutics, Inc. (ZVRA)
USD 8.0
(4.71%)
USD 8.0
(4.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 27.46 Million | 10.45 Million | 28.65 Million | 13.28 Million | 12.83 Million | - |
| Cost of Revenue | 2.94 Million | 343 Thousand | 2.05 Million | 1.3 Million | 2.94 Million | 324 Thousand |
| Gross Profit | 24.51 Million | 10.11 Million | 26.59 Million | 11.98 Million | 9.89 Million | -324 Thousand |
| Operating Expenses | 74.12 Million | 34.95 Million | 18.86 Million | 16.76 Million | 30.23 Million | 54.26 Million |
| Selling, General and Administrative Expenses | 35.08 Million | 15.34 Million | 8.7 Million | 7.92 Million | 10.81 Million | 12.5 Million |
| Research and Development Expenses | 39.8 Million | 19.61 Million | 10.16 Million | 8.84 Million | 19.41 Million | 41.75 Million |
| Other Expenses | -775 Thousand | - | - | - | - | - |
| Cost and Expenses | 77.06 Million | 35.3 Million | 20.92 Million | 18.06 Million | 33.17 Million | 54.26 Million |
| Operating Income | -49.6 Million | -24.84 Million | 7.72 Million | -4.78 Million | -20.33 Million | -55.9 Million |
| Interest Expense | 1.5 Million | 335 Thousand | 376 Thousand | 7.09 Million | 6.51 Million | 7.08 Million |
| Income Tax Expense | - | -786 Thousand | 34 Thousand | -34 Thousand | -22 Thousand | -126 Thousand |
| Earnings before Tax | -46.04 Million | -42.32 Million | -8.52 Million | -12.79 Million | -24.54 Million | -56.59 Million |
| Net Income | -46.04 Million | -41.54 Million | -8.55 Million | -12.76 Million | -24.52 Million | -56.46 Million |
| Earnings Per Share Basic | -1.30 | -1.20 | -0.29 | -3.21 | -13.23 | -50.39 |
| Earnings Per Share Diluted | -1.30 | -1.20 | -0.29 | -3.21 | -13.23 | -50.39 |
| Weighted Average Shares Outstanding | 35.45 Million | 34.48 Million | 29.76 Million | 3.98 Million | 1.85 Million | 1.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.45 Million | 34.48 Million | 29.76 Million | 3.98 Million | 1.85 Million | 1.12 Million |
| Gross Margin | 0.89 | 0.97 | 0.93 | 0.90 | 0.77 | - |
| EBIT Margin | -1.77 | -2.30 | 0.28 | -0.35 | -1.56 | - |
| Profit Margin | -1.68 | -3.97 | -0.30 | -0.96 | -1.91 | - |
| EBITDA | -48.59 Million | -25.52 Million | -7.88 Million | -5.43 Million | -17.72 Million | -53.94 Million |
| Earnings Before Tax Margin | -1.81 | -2.38 | 0.27 | -0.36 | -1.58 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.44 Million | 3.42 Million | 13.21 Million | 27.46 Million | 2.89 Million | 8.47 Million |
| Cost of Revenue | 6.68 Million | 3.26 Million | 2.78 Million | 3.95 Million | 144 Thousand | 677 Thousand |
| Gross Profit | -2.23 Million | 160 Thousand | 10.43 Million | 23.51 Million | 2.75 Million | 7.79 Million |
| Operating Expenses | 21.56 Million | 20.64 Million | 25.1 Million | 73.11 Million | 18.11 Million | 14.43 Million |
| Selling, General and Administrative Expenses | 12.6 Million | 9.93 Million | 14.65 Million | - | 5.81 Million | 7 Million |
| Research and Development Expenses | 8.95 Million | 10.71 Million | 10.44 Million | - | 12.29 Million | 7.43 Million |
| Other Expenses | -3.1 Million | -1.52 Million | - | - | - | - |
| Cost and Expenses | 28.24 Million | 23.91 Million | 27.88 Million | 77.06 Million | 18.25 Million | 15.11 Million |
| Operating Income | -23.79 Million | -20.48 Million | -14.67 Million | -49.6 Million | -15.36 Million | -6.64 Million |
| Interest Expense | 2.11 Million | 735 Thousand | 756 Thousand | 1.5 Million | 366 Thousand | 197 Thousand |
| Income Tax Expense | 70 Thousand | -70 Thousand | - | - | 177 Thousand | -74 Thousand |
| Earnings before Tax | -19.85 Million | -16.69 Million | -15.15 Million | -46.04 Million | -13.86 Million | -5.15 Million |
| Net Income | -19.92 Million | -16.62 Million | -15.15 Million | -46.04 Million | -14.04 Million | -5.08 Million |
| Earnings Per Share Basic | -0.48 | -0.40 | -0.40 | - | -0.40 | -0.15 |
| Earnings Per Share Diluted | -0.48 | -0.40 | -0.40 | - | -0.40 | -0.15 |
| Weighted Average Shares Outstanding | 41.89 Million | 41.77 Million | 37.89 Million | 35.45 Million | 34.72 Million | 33.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.89 Million | 41.77 Million | 37.89 Million | 35.45 Million | 34.72 Million | 33.89 Million |
| Gross Margin | -0.50 | 0.05 | 0.79 | 0.86 | 0.95 | 0.92 |
| EBIT Margin | -5.00 | -5.53 | -1.05 | - | -4.71 | -0.60 |
| Profit Margin | -4.48 | -4.85 | -1.15 | -1.68 | -4.85 | -0.60 |
| EBITDA | -22.23 Million | -18.92 Million | -13.88 Million | - | -13.62 Million | -5.09 Million |
| Earnings Before Tax Margin | -5.35 | -5.98 | -1.11 | -1.81 | -5.31 | -0.78 |
VIPCLOTHNG
UOM
LGP
ALGEC
NIPPOBATRY
POBS